Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumours of the Uterus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00839475
What this trial is testing

Investigation of the Uterine Cervix Using CervicalMD

Who this might be right for
Colposcopy
STI-Medical Systems 26
Testing effectiveness (Phase 2)Study completedNCT04380805
What this trial is testing

AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer

Who this might be right for
Recurrent Cervical CancerMetastatic Cervical Cancer
Akeso 30
Not applicableStudy completedNCT00258401
What this trial is testing

Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.

Who this might be right for
Cervical CancerDiarrheaProstate Cancer+2 more
Case Comprehensive Cancer Center 11
Early research (Phase 1)Looking for participantsNCT06400472
What this trial is testing

Sofe-M in Participants With Selected Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+4 more
Eli Lilly and Company 575
Not applicableStudy completedNCT00277082
What this trial is testing

Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung

Who this might be right for
Corpus UteriLung Cancer
University of New Mexico 24
Large-scale testing (Phase 3)Study completedNCT00552279
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 805
Testing effectiveness (Phase 2)Study completedNCT00301964
What this trial is testing

Bevacizumab in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Recurrent Endometrial Carcinoma
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)Study completedNCT03104699
What this trial is testing

AGEN2034 in Advanced Tumors and Cervical Cancer

Who this might be right for
Advanced CancerCervical Cancer
Agenus Inc. 211
Testing effectiveness (Phase 2)Looking for participantsNCT06319963
What this trial is testing

Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

Who this might be right for
HPV-Related Cervical CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma
Theravectys S.A. 72
Testing effectiveness (Phase 2)Study completedNCT02899793
What this trial is testing

Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer

Who this might be right for
Recurrent Endometrial Cancer
Yale University 25
Early research (Phase 1)Ended earlyNCT06264921
What this trial is testing

A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorSolid Tumor, AdultAdvanced Solid Tumor+26 more
NiKang Therapeutics, Inc. 23
Not applicableNot Yet RecruitingNCT07333326
What this trial is testing

Uterine Artery Doppler Flow Velocimetry Parameters for Predicting the Occurrence of Persistent Gestational Trophoblastic Neoplasia After Evacuation of Complete Hydatiform Mole

Who this might be right for
Gestational Trophoblastic NeoplasiaComplete Hydatiform Mole
Minia University 175
Testing effectiveness (Phase 2)Study completedNCT00319748
What this trial is testing

Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers

Who this might be right for
Breast CancerOvarian CancerEndometrial Cancer+1 more
Masonic Cancer Center, University of Minnesota 15
Testing effectiveness (Phase 2)Study completedNCT02744898
What this trial is testing

Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus

Who this might be right for
Endometrial Cancer
NYU Langone Health 23
Not applicableUnknownNCT04489706
What this trial is testing

Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation

Who this might be right for
Ovarian CancerEndometrial Cancer
Ruijin Hospital 20
Post-approval studies (Phase 4)Looking for participantsNCT07776821
What this trial is testing

An Exploratory Study on the Efficacy and Safety of Enlonstobart Combined With Concurrent Radiotherapy and Chemotherapy Following Induction Therapy With Enlonstobart Plus Chemotherapy in Patients With Locally Advanced Cervical Cancer.

Who this might be right for
Uterine Cervical Neoplasms
Tianjin Medical University Cancer Institute and Hospital 31
Testing effectiveness (Phase 2)Looking for participantsNCT07424664
What this trial is testing

A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer

Who this might be right for
Uterine Cervical Neoplasms, Recurrent; Uterine Cervical Neoplasms, Metastatic; Vulvar Neoplasms; Vaginal Neoplasms
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Large-scale testing (Phase 3)Study completedNCT00264732
What this trial is testing

Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix

Who this might be right for
Uterine Cervical Dysplasia
Eisai Inc. 251
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06724263
What this trial is testing

A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors

Who this might be right for
Recurrent Platinum-resistant Epithelial Ovarian CancerTriple Negative Breast Cancer (TNBC)Cervical Cancers+4 more
Tasly Biopharmaceuticals Co., Ltd. 120
Large-scale testing (Phase 3)Active Not RecruitingNCT04906993
What this trial is testing

Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Jiangsu HengRui Medicine Co., Ltd. 443
Next Page